Physician's Choice Probiotics 60 Billion CFU Review

Not necessarily — and this is the most important thing to understand before you buy on the number. CFU (colony-forming units) counts viable cells, but a bigger count of unstudied or mismatched strains does nothing extra. The clearest proof is Align: its B. infantis 35624 relieves IBS at just 1×10⁸ CFU/day (Whorwell 2006, PMID 16863564) because that exact strain at that dose is what the trial used. Seed reports AFU (a different viability unit), so '53.6B AFU' and '60B CFU' aren't directly comparable. Physician's Choice's 60B is a sensible dose for a broad daily generalist, but its panel prints species names only, with no strain codes, so you cannot match any of it to a trial. Buy it for the price and the prebiotic, not because 60 beats 50.

The maker says so; the label does not show it. The product listing states that it uses acid-resistant capsules, but the Supplement Facts panel prints the capsule as 'vegetable capsule (hypromellose, gellan gum)' and prints no enteric coating, delayed-release or other delivery design. Per our label-first rule, a claim that appears only in marketing is not a basis for a score, so we treat survivability as a plain capsule. The failure mode itself is real: stomach acid and bile kill many naked probiotic bacteria before they reach the colon. The front of the box does print 'No Refrigeration Necessary', which is about storage, not about surviving the stomach.

It may help, but it isn't the targeted tool — for IBS specifically, buy the studied strain. Ford 2014 (PMID 25070051) shows probiotics as a class improve IBS symptoms, so a broad 10-species blend like this can ease bloating and bowel comfort for some people. But the single best-evidenced IBS strain is Bifidobacterium infantis 35624 (Whorwell 2006), sold as Align, and the Hungin 2018 consensus (PMID 29460487) backs strain-specific selection for symptom relief. Physician's Choice prints no strain code at all, so there is no way to tell from the label whether any studied strain is inside. The clean decision: if you want broad, affordable everyday gut support without a subscription, this is a value option; if your dominant problem is IBS-type cramping and bloating, choose the named strain instead of a generalist blend.

Because you're paying for a generalist, not a premium documentation-and-survivability package. At ~$26/month with no subscription, Physician's Choice undercuts Seed (~$50) and Ritual (~$54) by delivering a 10-species blend and a 150 mg prebiotic blend — the core of the job — without the named strain panel, capsule-in-capsule or delayed-release engineering, postbiotic, or ingredient-traceability story those premium picks carry. That can be a fair trade for everyday buyers, but note what you give up: its label names species only, so you cannot see which strains you are getting, and its capsule is plain.

No — the front of the box prints 'No Refrigeration Necessary', which is part of its everyday-convenience appeal and a real advantage over picks that want cold storage, such as Garden of Life Women's and many Renew Life lots. Shelf stability matters because a probiotic meant to be refrigerated that sat warm in shipping can lose viability, so a product built to be stable at room temperature is more forgiving in the real world. As always, the label is the source of truth, and the potency you get at the end of the bottle is not stated: the panel gives 60 billion CFU without saying whether that is at manufacture or at expiration.

It's a genuine synbiotic. The panel prints a 150 mg prebiotic blend of organic inulin (from Jerusalem artichoke), organic acacia fiber and organic inulin (from chicory), with no individual amounts, so the strains come with something to ferment. That's a step more complete than a plain single-strain probiotic, though not as elaborate as Ritual's 3-in-1, which adds a tributyrin postbiotic on top. For an everyday value pick, probiotic plus a three-fiber prebiotic is a sensible, complete-enough formulation concept; the weak point is the probiotic half, where the species are named but the strains are not.

1. [1] Ford 2014 PMID 25070051 — Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Meta-analysis of 43 RCTs: probiotics as a class significantly reduced persistent IBS symptoms versus placebo (RR 0.79), with benefits on pain, bloating, and flatulence — while noting the best strains remain uncertain. The class-level support for a broad daily generalist like this, plus the caveat that a single diagnosis is better served by a matched strain.
2. [2] Whorwell 2006 PMID 16863564 — Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. RCT in 362 women: B. infantis 35624 at just 1×10⁸ CFU/day significantly relieved IBS pain and bloating. The textbook proof that the right strain at a modest dose beats a big CFU of unmatched strains — the reason this product's 60B headline isn't why it works.
3. [3] Hungin 2018 PMID 29460487 — Systematic review: probiotics in the management of lower gastrointestinal symptoms — an updated evidence-based international consensus. International primary-care consensus over 70 RCTs: specific probiotics reduce overall symptom burden and abdominal pain in some patients, and specified strains help prevent antibiotic-associated diarrhea. Supports a documented blend for general support while reinforcing strain-matching for specific diagnoses — the line between this generalist and the targeted picks.